Elevance Health appoints Steve Collis to board of directors

Elevance Health Inc. (NYSE: ELV) announced that Steve Collis will join its board of directors effective August 1. Collis will also serve on the board's Audit and Finance Committees.

Collis currently serves as Executive Chairman of the Board of Cencora, formerly known as AmerisourceBergen. He joined Cencora in 1994 and held the position of President and Chief Executive Officer from 2011 until becoming Executive Chairman in 2024.

"Steve brings a distinguished record of leadership, transformation, and operational excellence," said Ramey Peru, Chair of the Elevance Health Board of Directors, according to the company's statement. "His insights will support our continued focus on delivering high-quality care, driving innovation, and creating enduring value for the people and communities we serve."

During his tenure as CEO at Cencora, Collis led the company through strategic transformation and expansion of its global operations in the pharmaceutical and healthcare supply chain sector.

The appointment is part of Elevance Health's board refresh initiative to support the company's strategic objectives and governance structure. Peru noted that the addition reflects the company's commitment to board evolution and ensuring appropriate experience to support growth in the healthcare market.

Elevance Health provides healthcare services to over 109 million consumers through medical, pharmacy, behavioral, clinical, home health, and complex care solutions.

You May Also Be Interested In

• Molson Coors EMEA&APAC president steps back for medical leave
• Lenovo expands hybrid AI portfolio with new inferencing platforms
• Nebius selects Komodor platform for Kubernetes reliability ops